Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / COMMON-STOCK
-
Shares outstanding
-
7,227,333
-
Total 13F shares
-
49,383,993
-
Share change
-
-5,508,473
-
Total reported value
-
$46,782,011
-
Put/Call ratio
-
0.45%
-
Price per share
-
$0.95
-
Number of holders
-
81
-
Value change
-
-$6,015,885
-
Number of buys
-
40
-
Number of sells
-
38
Institutional Holders of Kezar Life Sciences Inc - COMMON-STOCK (KZR) as of Q4 2023
As of 31 Dec 2023,
Kezar Life Sciences Inc - COMMON-STOCK (KZR) was held by
81 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
49,383,993 shares.
The largest 10 holders included
SUVRETTA CAPITAL MANAGEMENT, LLC, Avidity Partners Management LP, BlackRock Inc., Prosight Management, LP, VANGUARD GROUP INC, MILLENNIUM MANAGEMENT LLC, SPHERA FUNDS MANAGEMENT LTD., ORBIMED ADVISORS LLC, Granahan Investment Management, LLC, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
81
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.